Who is sponsoring NCT00652067?

NCT00652067 is sponsored by Yale University.

What condition does NCT00652067 study?

NCT00652067 studies Infection, Mycobacterium Avium-Intracellulare.

Is NCT00652067 still recruiting?

NCT00652067 is currently completed. Last updated 2 April 2008.

Last reviewed 2008-04-02 · How we verify

NCT00652067

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IND for One Patient to Receive Clofazamine for Treatment of MAI

Completed Last updated 2 April 2008

What this trial tests

trial in Infection, Mycobacterium Avium-Intracellulare in 1 participant. Completed in 1 May 2007.

Timeline

1 May 2006

Primary endpoint
1 May 2007

1 May 2007

Quick facts

Lead sponsor	Yale University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1
Start date	1 May 2006
Primary completion	1 May 2007
Estimated completion	1 May 2007

Conditions studied

Infection, Mycobacterium Avium-Intracellulare — all drugs for Infection, Mycobacterium Avium-Intracellulare →

Sponsor

Yale University

Who can join

Eligibility, female only, with Infection, Mycobacterium Avium-Intracellulare. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00652067 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 2 April 2008

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00652067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing